Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.2.1077

Long Non-coding RNA GAS5 Functions as a Tumor Suppressor in Renal Cell Carcinoma  

Qiao, Hui-Ping (School of Radiation Medicine and Protection, Medical College of Soochow University)
Gao, Wei-Shi (Surgical oncology, Inner Mongolia Autonomous Region Hospital)
Huo, Jian-Xin (Department of Radio-oncology, The First Affiliated Hospital of Baotou Medical College)
Yang, Zhan-Shan (School of Radiation Medicine and Protection, Medical College of Soochow University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.2, 2013 , pp. 1077-1082 More about this Journal
Abstract
Background: Renal cell carcinoma (RCC) is a malignancy with a poor prognosis. We aimed to explore whether the expression of Long Non-Coding RNA (LncRNA) growth arrest-specific transcript 5 (GAS5) is associated with RCC genesis. Methods: We selected twelve clinical samples diagnosed for renal clear cell carcinoma and found that the LncRNA GAS5 transcript levels were significantly reduced relative to those in adjacent unaffected normal renal tissues. Results: In addition, expression of GAS5 was lower in the RCC cell line A498 than that in normal renal cell line HK-2. Furthermore, using functional expression cloning, we found that overexpression of GAS5 in A498 cells inhibited cell proliferation, induced cell apoptosis and arrested cell cycling. At the same time, the migration and invasion potential of A498 cells were inhibited compared to control groups. Conclusion: Our study provided the first evidence that a decrease in GAS5 expression is associated with RCC genesis and progression and overexpression of GAS5 can act as a tumor suppressor for RCC, providing a potential attractive therapeutic approach for this malignancy.
Keywords
Renal cell carcinoma; Long non-coding RNAs; GAS5;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Amit D, Hochberg A(2010). Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. J Transl Med, 8, 134.   DOI   ScienceOn
2 Birney E, Stamatoyannopoulos JA, Dutta A, et al (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816.   DOI   ScienceOn
3 Cho IC, Chung J (2012). Current status of targeted therapy for advanced renal cell carcinoma. Korean J Urol, 53, 217-28.   DOI   ScienceOn
4 Chow WH, Devesa SS, Warren JL, Fraumeni JF, Jr. (1999). Rising incidence of renal cell cancer in the United States. JAMA, 281, 1628-31.   DOI   ScienceOn
5 Gibb EA, Brown CJ, Lam WL(2011). The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 10, 38.   DOI   ScienceOn
6 Gutschner T, Diederichs S (2012).The Hallmarks of Cancer: A long non-coding RNA point of view. RNA Biol, 9, 703-19.   DOI
7 Hasenpusch G, Pfeifer C, Aneja MK, et al (2011). Aerosolized BC-819 inhibits primary but not secondary lung cancer growth. PLoS One, 6, e20760.   DOI
8 Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006). Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst, 98, 1331-4.   DOI   ScienceOn
9 Huarte M, Rinn JL (2010). Large non-coding RNAs: missing links in cancer? Hum Mol Genet, 19, R152-61.   DOI
10 Ito S, Koshikawa N, Mochizuki S, Takenaga K (2007). 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int J Oncol, 31, 261-8.
11 Janzen NK, Kim HL, Figlin RA, Belldegrun AS (2003). Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am, 30, 843-52.   DOI   ScienceOn
12 Kapranov P, St Laurent G, Raz T, et al (2010). The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol, 8, 149.   DOI   ScienceOn
13 Liang P, Pardee AB (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-71.   DOI
14 Linehan WM, Walther MM, Alexander RB, Rosenberg SA (1993). Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute. Semin Urol, 11, 41-3.
15 Ljungberg B, Campbell SC, Choi HY, et al (2006). The epidemiology of renal cell carcinoma. Eur Urol, 60, 615-21.
16 Mercer TR, Dinger ME, Mattick JS (2009). Long non-coding RNAs: insights into functions. Nat Rev Genet, 10, 155-9.   DOI   ScienceOn
17 Mevorach RA, Segal AJ, Tersegno ME, Frank IN (1992). Renal cell carcinoma: incidental diagnosis and natural history: review of 235 cases. Urology, 39, 519-22.   DOI   ScienceOn
18 Mizrahi A, Czerniak A, Levy T, et al (2009). Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med, 7, 69.   DOI   ScienceOn
19 Morrison LE, Jewell SS, Usha L, et al (2007). Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer, 46, 397-405.   DOI   ScienceOn
20 Mourtada-Maarabouni M, Hasan AM, Farzaneh F, Williams GT (2010). Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5). Mol Pharmacol, 78, 19-28.   DOI   ScienceOn
21 Nupponen NN, Carpten JD (2001). Prostate cancer susceptibility genes: many studies, many results, no answers. Cancer Metastasis Rev, 20, 155-64.   DOI   ScienceOn
22 Mourtada-Maarabouni M, Pickard MR, Hedge VL,et al (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene, 28, 195-208.   DOI   ScienceOn
23 Muller AJ, Chatterjee S, Teresky A, Levine AJ (1998). The gas5 gene is disrupted by a frameshift mutation within its longest open reading frame in several inbred mouse strains and maps to murine chromosome 1. Mamm Genome, 9, 773-4.   DOI
24 Nie L, Wu HJ, Hsu JM, et al (2012). Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res, 4, 127-50.
25 Raho G, Barone V, Rossi D, et al (2000). The gas 5 gene shows four alternative splicing patterns without coding for a protein. Gene, 256, 13-7.   DOI   ScienceOn
26 Schneider C, King RM, Philipson L (1988). Genes specifically expressed at growth arrest of mammalian cells. Cell, 54, 787-93.   DOI   ScienceOn
27 Sidi AA, Ohana P, Benjamin S, et al (2008). Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J Urol, 180, 2379-83.   DOI   ScienceOn
28 Smaldone MC, Davies BJ (2010). BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther, 12, 607-16.
29 Smedley D, Sidhar S, Birdsall S,et al (2000). Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer, 28, 121-5.   DOI
30 Smith CM, Steitz JA (1998). Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol, 18, 6897-909.
31 Soto-Vega E, Arroyo C, Richaud-Patin Y, et al (2009). P-glycoprotein activity in renal clear cell carcinoma. Urol Oncol,27, 363-6.   DOI   ScienceOn
32 Tsai MC, Spitale RC, Chang HY (2011). Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res, 71, 3-7.
33 van Spronsen DJ, Mulders PF, De Mulder PH (2005). Novel treatments for metastatic renal cell carcinoma. Crit Rev Oncol Hematol, 55, 177-91.   DOI   ScienceOn
34 Wilusz JE, Sunwoo H, Spector DL (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 23, 1494-504.   DOI   ScienceOn